Tumour response evaluation with fluorodeoxyglucose positron emission tomography: research technique or clinical tool? (Q34256387)

31 July 2017

7 references

3 April 2019

19 June 2019

2 October 2019

18 November 2019

27 October 2020

23 November 2020

8 February 2021

Tumour response evaluation with fluorodeoxyglucose positron emission tomography: research technique or clinical tool? (English)

1 reference

positron emission tomography

31 July 2017

2 references

3 April 2019

19 June 2019

1 reference

2 October 2019

1 reference

18 November 2019

1 reference

27 October 2020

1 reference

23 November 2020

1 reference

8 February 2021

H Anderson

1 reference

31 July 2017

N Singh

series ordinal

1 reference

31 July 2017

K Miles

series ordinal

1 reference

31 July 2017

publication date

4 October 2010

8 references

31 July 2017

3 April 2019

19 June 2019

2 October 2019

18 November 2019

27 October 2020

23 November 2020

8 February 2021

7 references

31 July 2017

19 June 2019

2 October 2019

18 November 2019

27 October 2020

23 November 2020

8 February 2021

10 Spec no A

1 reference

31 July 2017

page(s)

S68-72

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

PET-CT in oncology: making the most of CT

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Warburg revisited: imaging tumour blood flow and metabolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Revised response criteria for malignant lymphoma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2967135

Reproducibility of metabolic measurements in malignant tumors using FDG PET

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20880775

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1102/1470-7330.2010.9088

1 reference

release_3y4626js3fdfrnaogkyjkkdvja

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3y4626js3fdfrnaogkyjkkdvja

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

2967135

1 reference

31 July 2017

1 reference